RESUMO

OBJECTIVE: Oral malignant infiltrations (OMI) are relevant for the diagnosis and prognosis of leukemia/lymphoma. This study analysed the oral health status and OMI of individuals with leukemia/lymphoma. MATERIALS AND METHODS: A retrospective analysis (2010-2021) of data from individuals seen at a specialized hospital-based dental service in Brazil. RESULTS: A total of 781 cases of leukemia/lymphoma were surveyed. Acute lymphoblastic leukemia (30.1%), acute myeloid leukemia (AML; 26.0%), and non-Hodgkin lymphoma (22.2%) were the most common diagnoses. The first (21.3%) and second (19.3%) decades of life were the most affected. Overall, dental caries (36.7%) and periodontal changes (34.6%) were the most frequent oral conditions. OMI occurred in 25 (3.2%) individuals. Lesions mainly involved the gingiva (80%) and patients diagnosed with AML (64%). Death (p < 0.001) and worse periodontal condition (p = 0.036) were more frequent among adults with OMI than among those without OMI. Death (p = 0.002) was more frequent among paediatric individuals with OMI than among those without OMI. When controlling for underlying disease, no association was observed between OMI and these outcomes. CONCLUSION: Oral status of individuals with leukemia, particularly those with acute leukemia or lymphoma, should be closely monitored since one or multiple conditions may occur, including OMI, which may influence disease outcomes.

Assuntos

RESUMO

Este trabalho realizou um estudo retrospectivo dos prontuários do Hospital das Clínicas (HC) da Universidade Federal de Minas Gerais (UFMG). Foram incluídos os indivíduos admitidos no período de 2010 a 2021 com diagnóstico de leucemia/linfoma e que foram avaliados pela equipe do Serviço de Odontologia do HC­UFMG. Foram coletados dados demográficos, características clínicas da doença de base e da cavidade bucal e presença de infiltração oral maligna. O teste t não pareado foi utilizado para avaliar os hemogramas e o teste McNemar para comparar indivíduos que desenvolveram infiltração oral maligna e aqueles que não desenvolveram. A significância estatística foi estabelecida como p<0,05. Adicionalmente, uma revisão da literatura de relatos de casos e séries de casos foi realizada em quatro bases de dados eletrônicas (PubMed, Web of Science, Scopus e Embase). Dos 781 prontuários analisados, a leucemia linfocítica aguda (30,1%) foi o diagnóstico mais frequente. Pacientes nas duas primeiras décadas de vida foram mais acometidos pela doença de base. Cárie (36,7%) e alterações periodontais (34,6%) foram as condições bucais mais observadas. Infiltração oral maligna ocorreu em 25 (3,2%) indivíduos, envolvendo principalmente a gengiva (80%) e indivíduos diagnosticados com leucemia mieloide aguda (64%). Comparando os dados de pacientes pediátricos que desenvolveram infiltração maligna e aqueles que não desenvolveram, a proporção de óbitos foi maior naqueles que tiveram infiltração (p=0,002), enquanto em adultos, aqueles que desenvolveram infiltração exibiram pior condição periodontal e maior proporção de óbitos (p<0,001). Dados da revisão da literatura demonstraram que a infiltração oral maligna foi mais frequente na gengiva (37%) e em pacientes com leucemia mieloide aguda (47%). As principais características clínicas e de imagem associadas à infiltração oral foram aumento de volume e lesões osteolíticas. Em conjunto, os dados sugerem a importância do monitoramento clínico odontológico de pacientes com leucemia/linfoma considerando os piores desfechos clínicos relacionados à infiltração dos tecidos orais.

This work carried out a retrospective study of the medical records at the Hospital das Clínicas (HC), Universidade Federal de Minas Gerais (UFMG). Individuals admitted in the period from 2010 to 2021 with a diagnosis of leukaemia/lymphoma and who were evaluated by the team of the dental service of HC­UFMG were included. Demographic data, clinical characteristics of the underlying disease and oral cavity, and presence of malignant oral infiltration were collected. The unpaired t test was employed to assess the blood count and the McNemar test to compare individuals who developed malignant oral infiltration and those who did not. Statistical significance was set at p<0.05. Additionally, a literature review of case reports and case series was undertaken in four electronic databases (PubMed, Web of Science, Scopus, and Embase). Of the 781 medical records analysed, acute lymphocytic leukaemia (30.1%) was the most frequent diagnosis. Patients in the first two decades of life were more affected by the underlying disease. Caries (36.7%) and periodontal changes (34.6%) were the most frequently observed oral conditions. Oral malignant infiltration took place in 25 (3.2%) individuals, mainly involving the gingiva (80%) and individuals diagnosed with acute myeloid leukaemia (64%). Comparing data from paediatric patients who developed malignant infiltration and those who did not, the proportion of deaths was higher in those who had infiltration (p=0.002), while in adults, those who developed infiltration had worse periodontal status and a higher proportion of death (p<0.001). Data from the literature review showed that oral malignant infiltration was more frequent in the gingiva (37%) and in patients with acute myeloid leukaemia (47%). The main clinical and imaging features associated with oral infiltration were swelling and osteolytic lesions. Altogether, the data suggest the importance of clinical dental monitoring of patients with leukaemia/lymphoma considering the worst clinical outcomes related to oral tissue infiltration.

Assuntos

RESUMO

BACKGROUND: Leukemic involvement of the eyes is rare, therefore, treatment relies on previous case reports. The treatment of ocular complications poses additional difficulties, because the eye is considered as a pharmacological "sanctuary" for patients with acute lymphoblastic leukemia (ALL). Therefore, radiotherapy is the main therapeutic choice; however, it might lead to many important side effects. To the best of our knowledge, this is the first case report of a bilateral leukemic optic nerve infiltration that remitted with chemotherapy without adjuvant radiotherapy. CASE PRESENTATION: A 30-year-old female patient with previous history of remitted ALL presented with a one-week history of floaters in her right eye. Her ophthalmological exam showed remarkable optic disc swelling, in both eyes. She was diagnosed with ALL relapse presenting as a bilateral optic nerve leukemic infiltration. Local radiotherapy was planned for both eyes, however, due to efficient recovery with chemotherapy, it was cancelled. Allogenic bone marrow transplantation was subsequently performed. The patient is being followed up and ALL remitted. CONCLUSION: Leukemia relapse on central nervous system, despite rare, is a sign of poor prognosis and requires prompt treatment. Its occurrence on ocular tissues is even rarer. It is hypothesized that the blood-brain barrier limits the delivery of chemotherapeutic drugs to the eye and infiltration of the optic nerve by leukemic cells might prejudice the flow of cerebrospinal fluid between the cranial space and the optic disc.

Assuntos

RESUMO

BACKGROUND: T-cell prolymphocytic leukemia (T-PLL) is a T-cell lymphoproliferative disorder that frequently involves the skin. The objective was to describe two cases of T-PLL with cutaneous involvement and to present a review of the literature concerning the clinical characteristics, differential diagnosis and treatment of these patients. CASE REPORTS: 1) 79 year-old man, with a previous diagnosis of T-PLL based on a laboratory incidental finding. He had been treated with alemtuzumab, but it had to be interrupted due to recurrent infections. After interrupting the treatment, the patient developed a symmetrical rash on his extremities. The skin biopsy demonstrated TPLL infiltration. 2) 28 year-old man that presented with asthenia and lymphocytosis. He also showed a purpuric rash on his trunk and facial erythema. Histopathology of the skin and bone marrow confirmed the diagnosis of T-PLL with cutaneous involvement. CONCLUSIONS: T-cell prolymphocytic leukemia accounts for 2% of mature leukemias in adults. Skin involvement is reported in 20-50% of the patients. The characteristic features are facial involvement, purpuric lesions and symmetry of the rash, although there are atypical manifestations as well. Differential diagnosis includes other T-cell lymphoproliferative disorders with hematologic and skin involvement, such as Sézary syndrome. Patients with T-PLL may show cutaneous infiltration at the moment of debut or relapse of the disease. The skin is an accessible organ for taking samples to study and diagnose these patients.

INTRODUCCIÓN: La leucemia prolinfocítica T (LPL-T) es una neoplasia hematológica del grupo de síndromes linfoproliferativos T que con frecuencia produce infiltración cutánea. Se presentan dos casos de LPL-T con afectación cutánea y se revisa la literatura en cuanto a características clínicas, diagnóstico diferencial y tratamiento de estos pacientes. CASOS CLÍNICOS: 1) Varón de 79 años diagnosticado de LPL-T tras un hallazgo analítico incidental. Tras suspender el tratamiento con alemtuzumab por infecciones recurrentes, comenzó con lesiones cutáneas maculopapulosas eritematopurpúricas que afectaban la raíz de las extremidades. La biopsia cutánea confirmó la infiltración por su enfermedad de base. 2) Varón de 28 años que debutó con astenia y hallazgos analíticos de leucocitosis. Había comenzado además con lesiones purpúricas en el tronco y eritema malar bilateral. El estudio de médula ósea y la biopsia cutánea confirmaron el diagnóstico de LPL-T con infiltración cutánea. CONCLUSIONES: La LPL-T corresponde al 2% de las leucemias linfocíticas maduras en los adultos. Entre el 20% y el 50% de los pacientes presentan afectación cutánea, con predominio en la región facial, y son característicos el eritema, la púrpura y la simetría, aunque existen manifestaciones atípicas. El diagnóstico diferencial incluye otros síndromes linfoproliferativos T con afectación cutánea y en sangre periférica, entre los que destaca el síndrome de Sézary. Los pacientes con LPL-T pueden presentar afectación cutánea en el debut o en una recidiva de la enfermedad. La piel representa un órgano accesible para la toma de muestras y para el diagnóstico y el estudio de estos pacientes.

RESUMO

RESUMEN La leucemia es una proliferación neoplásica de las células progenitoras del origen tejido hematopoyético y se conoce como leucemia cutis a toda la infiltración en de la piel por el proceso neoplásico. Se presenta el caso de una mujer de 60 años de edad con un cuadro de tres semanas de evolución de aparición de pápulas y placas eritemato-violáceas, inicialmente tratada como cuadro alérgico. Su diagnóstico final fue leucemia cutis secundaria a leucemia mieloide aguda, presentando evolución clínica tórpida.

ABSTRACT Leukemia is a neoplastic proliferation of progenitor cells of hematopoietic tissue origin and the infiltration of the neoplastic process into the skin is known as leukemia cutis. We present the case of a 60-year-old woman with a three-week history of the appearance of erythematous-violet papules and plaques, initially treated as an allergic condition. Her final diagnosis was leukemia cutis secondary to acute myeloid leukemia, presenting a torpid clinical course.

RESUMO

Leukemic infiltration of the gingival tissue associated or not with gingival enlargement may be the first manifestation of acute leukemia, despite being rarely reported in the literature. A 10-year-old female patient presented with a 1-month history of an asymptomatic, firm, and pinkish-red generalized gingival overgrowth. There was no bone resorption. Incisional biopsy of the gingival tissue was performed, with histopathological examination revealing a diffuse and hypercellular infiltration of monocytoid cells. The patient was referred to a hematologist and underwent a bone marrow biopsy, which led to a conclusive diagnosis of acute myeloid leukemia. The patient was treated with chemotherapy and we observed regression of gingival enlargement after 4 weeks from the initial therapy.

Assuntos

RESUMO

Abstract Wolf's isotopic response designates the appearance of two subsequent unrelated dermatoses in the same anatomic location. We report the case of a 51-year-old man with a medical history of chronic lymphocytic leukemia without known extra-hematopoietic involvement. The patient developed a disseminated papulo-vesiculous eruption, diagnosed as varicella. Few days after recovering, an erythematous and violaceous papular dermatosis with histopathological examination compatible with leukemic infiltration appeared on the scars of previous herpetic lesions. Complete remission was obtained under systemic corticotherapy, without cutaneous recurrence or blastic transformation. Wolf's isotopic response is attributed to a localized immunologic imbalance following a certain stimulus. In this patient, herpetic infection acted as a local spur for inaugural cutaneous leukemic infiltration, with no impact on the prognosis for the underlying disease.

Assuntos

RESUMO

Blastic plasmacytoid dendritic cell neoplasm is a rare and aggressive hematodermic neoplasia with frequent cutaneous involvement and leukemic dissemination. We report the case of a 76-year-old man with a 2 month history of violaceous nodules and a tumor with stony consistency, located on the head, and mandibular, cervical and supraclavicular lymphadenopathies. Multiple thoracic and abdominal adenopathies were identified on computerized tomography. Flow cytometry analysis of the skin, lymph node and bone marrow biopsies demonstrated the presence of plasmocytoid dendritic cell neoplastic precursor cells (CD4+, CD45+, CD56+ and CD123+ phenotype). After initial clinical and laboratorial complete remission with chemotherapy, the patient died due to relapse of the disease associated with the appearance of a cervical mass with medullary compromise.

A neoplasia blástica de células dendríticas plasmocitóides é uma neoplasia hematodérmica rara, agressiva, com frequente envolvimento cutâneo e disseminação leucêmica. Relatamos o caso de um homem de 76 anos com quadro clínico com 2 meses de evolução caracterizado por nódulos e tumor de tonalidade violácea, de consistência pétrea, localizados na cabeça, e linfadenopatias mandibular, cervicais e supraclaviculares. Identificaram-se múltiplas adenopatias torácicas e abdominais em tomografia computorizada. A análise por citometria de fluxo de biópsias cutânea, ganglionar e óssea demonstrou a presença de precursores neoplásicos das células dendríticas plasmocitóides (fenótipo CD4+, CD45+, CD56+ e CD123+). Após remissão clínica e laboratorial completa inicial com quimioterapia, veio a falecer por recaída da doença associada ao aparecimento de massa cervical com compromisso medular.

Assuntos